TORONTO and BOSTON , April 25, 2017 / — Bionik Laboratories Corp. (BNKL) (“Bionik” or the “Company”), a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home, announced today it has shipped its 250th interactive robotic therapy system, an important milestone as it continues to penetrate the rehabilitation industry and bring its innovative technology to a broader patient-base.
Bionik’s robotic solutions are currently providing effective and affordable patient care with respect to treatment of neurological disorders in 20 countries and in over 200 hospitals. Bionik has seven robotic products, of which three are FDA-cleared and in the market globally, and four products that are in various stages of development. Its InMotion ARM, InMotion HAND, and InMotion WRIST interactive robotic therapy systems sense a patient’s movement and respond to a patient’s continually-changing ability, all in real time.
“We are excited to reach this milestone as a company and to bring our robotic systems into medical facilities to provide innovative rehabilitation solutions for patients across the country,” said Michal Prywata, co-founder, chief technology officer and director of Bionik Laboratories. “Neurological disorders afflict millions of people each year, but current physical therapy methods are simply too limited to help patients regain the mobility they have lost. We believe our robotic systems offer the best in patient care and our continued penetration into the market showcases that.”
Neurological disorders affect a person’s brain, spine, or nerves and can be characterized by paralysis, muscle weakness, poor coordination, loss of sensation, and a number of other symptoms. A major cause is stroke – approximately 15 million people suffer from stroke each year – with one third remaining permanently disabled in some form. Other instances of injuries occur from traumatic events such as car accidents or battlefield injuries, leaving patients with partial or full paralysis.
“Medical treatment options are changing as technology continues to evolve. Bionik is at the forefront of a shift in the way neurological disorders are managed, utilizing robotics, artificial intelligence, and real time data and analytics to provide a significantly enhanced form of patient care,” Prywata continued. “With our InMotion systems and additional products in development, we feel that the Company is uniquely positioned to revolutionize the industry and become the standard of rehabilitation care.”
For more information visit: www.bioniklabs.com